The ever-growing cell therapy community continue to strive for durable, safe and accessible treatments for oncology, and are now expanding this goal to autoimmune indications too. To achieve this, developers are putting their trust in industry partners to accelerate development and pipeline progression.

The 9th CAR-TCR Summit is the premier meeting in the cell therapy calendar, providing an unmatched opportunity to connect with decision-makers from small and large biotech, pharma and academia, to spark connections, foster relationships and demonstrate your commitment to the shared objective of delivering these life-saving treatments to patients.

Get in touch now to begin discussing your bespoke package.